Showing results (121-130 of 559) with videos related to

Sort By:
Pageof 56
Leukemia Research|June 14, 2025
A phase 2 study of itacitinib alone or in combination with low-dose ruxolitinib in patients with myelofibrosisMoshe Talpaz, Aaron T Gerds, Roger Lyons, et al.
Journal of Periodontology|May 14, 1998
Changes in peri-implant tissues subjected to orthodontic forces and ligature breakdown in monkeysM B Hürzeler, C R Quiñones, R J Kohal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDSAaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Leukemia Research|February 27, 2022
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemiaNaveen Pemmaraju, Aaron T Gerds, Jingbo Yu, et al.
Leukemia|December 8, 2016
The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignanciesA Statler, T Radivoyevitch, C Siebenaller, et al.
Acta Haematologica|January 10, 2022
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and OutcomesAaron T Gerds, Jingbo Yu, Robyn M Scherber, et al.
Zhonghua Yi Xue Za Zhi|November 1, 1989
[AFP gene expression and antigenic protein localization in the cells of hepatocellular carcinoma and its surrounding tissues]Y M Dai
Zhonghua Yi Xue Za Zhi|November 20, 2023
[Concept and understanding of non-radiographic axial spondyloarthritis]S M Dai
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2015
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array TestingCecilia C S Yeung, Aaron T Gerds, Min Fang, et al.
Annals of Hematology|April 5, 2018
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international studyJ Mascarenhas, E Virtgaym, M Stal, et al.
Pageof 56